Design and Implementation of The Integration of Additive Manufacturing into Traditional Manufacturing Processes

Abstract

The pharmaceutical industry is undergoing a rapid transformation driven by technological advances, economic pressures, and changing consumer demands. Integrating additive manufacturing (AM) into traditional processes offers opportunities for personalized medicine, waste reduction, and enhanced production efficiency, while maintaining regulatory compliance. This study proposes a framework based on the DMADV methodology to design and validate a hybrid manufacturing model supporting personalized drug production. Preliminary results suggest that a structured approach can overcome technical and regulatory barriers, facilitating the adoption of AM in the pharmaceutical sector. The developed framework provides a practical pathway for companies to implement innovative manufacturing strategies, improving responsiveness to market needs and advancing industry competitiveness in a dynamic environment. Key Terms ⎯ Additive Manufacturing, DMADV Method, Hybrid Process, Personalization, Pharmaceutical Industry.